Roth Capital Predicts Stronger Earnings for Core Scientific

Core Scientific, Inc. (NASDAQ:CORZ) – Analysts at Roth Capital upped their Q2 2025 EPS estimates for Core Scientific in a research report issued on Thursday, May 8th. Roth Capital analyst D. Aftahi now forecasts that the company will earn ($0.11) per share for the quarter, up from their previous forecast of ($0.12). The consensus estimate for Core Scientific’s current full-year earnings is $0.52 per share. Roth Capital also issued estimates for Core Scientific’s Q4 2025 earnings at ($0.07) EPS and FY2025 earnings at ($0.40) EPS.

Core Scientific (NASDAQ:CORZ) last announced its quarterly earnings results on Wednesday, May 7th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.02. The firm had revenue of $79.53 million during the quarter, compared to analysts’ expectations of $92.04 million. The company’s quarterly revenue was down 55.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.78 earnings per share.

Several other research analysts have also recently weighed in on the stock. Cantor Fitzgerald decreased their price objective on shares of Core Scientific from $24.00 to $21.00 and set an “overweight” rating on the stock in a research report on Thursday, February 27th. Craig Hallum started coverage on Core Scientific in a research note on Tuesday, January 21st. They issued a “buy” rating and a $24.00 price target for the company. HC Wainwright reaffirmed a “buy” rating and issued a $17.00 price target on shares of Core Scientific in a research note on Tuesday, March 11th. Keefe, Bruyette & Woods initiated coverage on Core Scientific in a research report on Monday, January 27th. They set an “outperform” rating and a $22.00 price objective for the company. Finally, Compass Point lowered their price target on Core Scientific from $26.00 to $20.00 and set a “buy” rating for the company in a research report on Tuesday, February 25th. Fifteen investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Core Scientific currently has a consensus rating of “Buy” and an average price target of $19.07.

Core Scientific Trading Up 6.0%

CORZ stock opened at $9.88 on Monday. The company’s 50 day moving average is $7.93 and its 200 day moving average is $12.04. The stock has a market cap of $2.91 billion, a price-to-earnings ratio of -1.83 and a beta of 6.66. Core Scientific has a 1-year low of $3.46 and a 1-year high of $18.63.

Institutional Investors Weigh In On Core Scientific

Large investors have recently made changes to their positions in the company. Wellington Shields & Co. LLC bought a new position in shares of Core Scientific during the 4th quarter valued at approximately $26,000. First Horizon Advisors Inc. purchased a new stake in shares of Core Scientific during the 4th quarter worth approximately $34,000. Newbridge Financial Services Group Inc. purchased a new stake in shares of Core Scientific during the 4th quarter worth approximately $42,000. Vestcor Inc purchased a new stake in Core Scientific during the 4th quarter valued at $66,000. Finally, Emerald Mutual Fund Advisers Trust purchased a new stake in Core Scientific during the 1st quarter valued at $38,000.

Insider Buying and Selling

In other Core Scientific news, Director Todd A. Becker sold 134,250 shares of the business’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $10.75, for a total transaction of $1,443,187.50. Following the completion of the sale, the director now directly owns 195,687 shares in the company, valued at $2,103,635.25. The trade was a 40.69% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jordan Levy purchased 62,500 shares of the business’s stock in a transaction on Thursday, March 6th. The shares were purchased at an average price of $8.01 per share, with a total value of $500,625.00. Following the completion of the purchase, the director now owns 306,887 shares in the company, valued at approximately $2,458,164.87. This trade represents a 25.57% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.40% of the stock is owned by corporate insiders.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.